Page last updated: 2024-08-23

etoposide and Body Weight

etoposide has been researched along with Body Weight in 51 studies

Research

Studies (51)

Timeframe	Studies, this research(%)	All Research%
pre-1990	21 (41.18)	18.7374
1990's	10 (19.61)	18.2507
2000's	13 (25.49)	29.6817
2010's	6 (11.76)	24.3611
2020's	1 (1.96)	2.80

Authors

Authors	Studies
Bach, E; Brückner, M; Franke, GN; Heyn, S; Jentzsch, M; Leiblein, S; Niederwieser, D; Pfannes, R; Platzbecker, U; Pönisch, W; Remane, Y; Rieprecht, S; Schwind, S; Vucinic, V	1
Ou, Y; Sun, G; Wang, H; Zhang, Z	1
Ding, Z; Hai, Z; Kiran, S; Liang, G; Liu, Y; Wang, L; Zhang, H	1
Boddy, AV; Duong, JK; Errington, J; Ladenstein, R; Nath, CE; Shaw, PJ; Veal, GJ	1
Ansell, SM; Costa, LJ; Inwards, DJ; Johnston, PB; Litzow, MR; Micallef, IN; Porrata, LF	1
Auvrignon, A; Chastagner, P; Corradini, N; Doz, F; Gentet, JC; Giraud, C; Leblond, P; Rey, E; Rubie, H; Treluyer, JM; Urien, S; Vassal, G	1
Diament, J; Freitas, FR; Maranhão, RC; Tavares, ER	1
Baheti, G; Davda, JP; Gordon, BB; Gwilt, PR; Manouilov, KK; McGuire, TR; Wall, D	1
Akamine, S; Ayabe, H; Inoue, M; Muraoka, M; Nagayasu, T; Oka, T; Shima, Y; Shimokawa, I; Shirafuji, T; Sumida, Y; Yamashita, H	1
Ball, ED; Chen, J; Mokotoff, M; Shultz, LD; Zhong, R; Zhou, J	1
Akaike, T; Fang, J; Greish, K; Maeda, H; Sawa, T	1
Nagase, S; Ohkuma, S; Sato, S; Shimosato, K; Watanabe, S	1
Freymüller, E; Miraglia, SM; Sasso-Cerri, E; Stumpp, T	1
Barbacid, M; Dubus, P; Hunt, SL; Malumbres, M; Martín, A; Odajima, J; Ortega, S	1
Abramjuk, C; Jung, K; Krell, HW; Lein, M; Loening, SA; Rothaug, W	1
Chan, G; Lotocka-Reysner, H; Strahlendorf, C	1
Aoyama, T; Hagiwara, S; Imataki, O; Inoue, N; Kataoka, T; Katsumata, M; Katsuta, T; Kawakami, K; Mochizuki, T; Motokawa, S; Tamai, Y; Yoshida, T	1
Boutin, P; Carcassone, Y; Cupissol, D; Michel, FB; Plagne, R; Serrou, B	1
Berdel, WE; Diehl, V; Graubner, M; Gropp, C; Klippstein, T; Mende, S; Mitrou, PS	1
Berdel, WE; Diehl, V; Graubner, M; Gropp, C; Klippstein, TH; Mende, S; Mitrou, PS	1
Barkley, HT; Benjamin, RS; Bodey, GP; Ertel, M; Freeman, MB; Mountain, CF; Smith, TL; Valdivieso, M	1
Brunner, KW; Cavalli, F; Goldhirsch, A; Joss, R; Kaplan, S; Obrecht, JP; Sonntag, R; Weber, W	1
Hagiwara, A; Itoh, M; Lee, JS; Muranishi, S; Sasabe, T; Takahashi, T; Tashima, S; Yoneyama, C	1
Abe, T; Kawano, Y; Makimoto, A; Nakagawa, R; Okamoto, Y; Saito, S; Sato, J; Shimizu, T; Suzue, T; Takaue, Y	1
Kanzawa, F; Kondo, H; Nishio, K; Saijo, N; Saito, S	1
Carthew, P; Cohen, GM; Dinsdale, D; Snowden, RT; Sun, XM	1
Nakano, K; Takechi, T; Takeda, S; Uchida, J	1
Berthold, F; Boos, J; Euting, T; Jürgens, H; Krümpelmann, S; Schulze-Westhoff, P	1
Goya, T; Koshiishi, Y; Miya, T; Nogami, H; Sasaki, Y; Yanagida, O	1
Akhtar, R; Clothier, B; Festing, MF; MacFarlane, M; Robinson, S; Smith, AG; Yang, AL	1
Chandra, S; Gupta, SK; Kochupillai, V; Sengupta, S; Tyagi, P	1
Kagawa, M; Kasai, Y; Kawaguchi, M; Nagaoka, Y; Wachi, M	1
Asai, T; Baba, K; Irimura, K; Oku, N; Shimizu, K; Takada, M	1
Kreis, W; Soricelli, A	1
Hagiwara, A; Itoh, M; Iwamoto, A; Lee, M; Sakakura, C; Sasabe, T; Shimotuma, M; Shobayashi, S; Takahashi, T; Yoneyama, C	1
Aida, I; Nishida, M; Sekiguchi, I; Suzuki, M; Tamada, T	1
Barkley, HT; Benjamin, RS; Bodey, GP; Frankmann, C; Jeffries, DG; McMurtrey, MJ; Murphy, WK; Valdivieso, M; Welch, SR	1
Amato, G; Broggini, M; Colombo, T; D'Incalci, M; Erba, E; Vaghi, M	1
Ettinger, DS; Finkelstein, DM; Ruckdeschel, JC	1
Chikazawa, H; Hamajima, Y; Ishikawa, K; Kadota, T; Kawano, S; Kuroyanagi, K; Ohta, K; Ohta, S; Takahashi, N; Takeuchi, Y	1
Hamajima, Y; Ishikawa, K; Kadota, T; Kai, S; Kawano, S; Kohmura, H; Kuroyanagi, K; Ohta, K; Ohta, S; Takahashi, N	9
Hamajima, Y; Ishikawa, K; Kadota, T; Kai, S; Kawano, S; Kohmura, H; Kuroyanagi, K; Ohta, S; Takahashi, N; Tanaka, T	1
Bailleul, F; Horvath, C; Lévi, F; Mathé, G; Mechkouri, M; Reinberg, A; Roulon, A	1

Trials

6 trial(s) available for etoposide and Body Weight

Article	Year
Developmental pharmacokinetics of etoposide in 67 children: lack of dexamethasone effect. Cancer chemotherapy and pharmacology, 2011, Volume: 67, Issue:3 Topics: Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Body Weight; Carboplatin; Child; Child, Preschool; Cytochrome P-450 CYP3A; Dexamethasone; Drug Interactions; Etoposide; Humans; Infant; Models, Biological; Neoplasms; Nonlinear Dynamics; Ondansetron; Polymorphism, Single Nucleotide	2011
Clinical pharmacology of etoposide in children undergoing autologous stem cell transplantation for various solid tumours. Xenobiotica; the fate of foreign compounds in biological systems, 2013, Volume: 43, Issue:3 Topics: Adolescent; Age Distribution; Body Weight; Child; Child, Preschool; Confidence Intervals; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Models, Biological; Neoplasms; Transplantation, Autologous; Young Adult	2013
Parenteral intravenous nutrition (PIVN) as an adjunct to chemotherapy in small cell anaplastic lung carcinoma. Cancer treatment reports, 1981, Volume: 65 Suppl 5 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Bone Marrow; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Gastrointestinal Diseases; Humans; Ifosfamide; Lung Neoplasms; Male; Methotrexate; Middle Aged; Parenteral Nutrition; Procarbazine; Random Allocation; Vincristine	1981
Role of intravenous hyperalimentation as an adjunct to intensive chemotherapy for small cell bronchogenic carcinoma. Cancer treatment reports, 1981, Volume: 65 Suppl 5 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Bone Marrow; Carcinoma, Bronchogenic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Gastrointestinal Diseases; Humans; Ifosfamide; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neutropenia; Parenteral Nutrition; Procarbazine; Vincristine	1981
Steady-state levels and bone marrow toxicity of etoposide in children and infants: does etoposide require age-dependent dose calculation? Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:12 Topics: Adolescent; Aging; Body Surface Area; Body Weight; Bone Marrow Diseases; Child; Child, Preschool; Dose-Response Relationship, Drug; Etoposide; Humans; Individuality; Infant; Infusions, Intravenous; Neuroblastoma	1995
The influence of relative body weight on toxicity of combination chemotherapy with cisplatin and etoposide. Cancer chemotherapy and pharmacology, 1998, Volume: 42, Issue:5 Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Body Surface Area; Body Weight; Carcinoma, Non-Small-Cell Lung; Cisplatin; Creatinine; Esophageal Neoplasms; Etoposide; Female; Hematologic Tests; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Sex Factors; Thrombocytopenia	1998

Other Studies

45 other study(ies) available for etoposide and Body Weight

Article	Year
Analysis of stem cell collections in adult patients with Ewing sarcoma. Transfusion, 2022, Volume: 62, Issue:8 Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Child; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Sarcoma, Ewing; Stem Cells; Vincristine; Young Adult	2022
Transcription activator, hyaluronic acid and tocopheryl succinate multi-functionalized novel lipid carriers encapsulating etoposide for lymphoma therapy. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 91 Topics: Animals; Antineoplastic Agents; Body Weight; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Liberation; Endocytosis; Etoposide; Humans; Hyaluronic Acid; Inhibitory Concentration 50; Lipids; Lymphoma; Male; Mice, Inbred C57BL; Nanoparticles; Particle Size; Proton Magnetic Resonance Spectroscopy; Static Electricity; Succinates; tat Gene Products, Human Immunodeficiency Virus; Tissue Distribution; Tocopherols	2017
Alkaline phosphatase-triggered assembly of etoposide enhances its anticancer effect. Chemical communications (Cambridge, England), 2018, Feb-15, Volume: 54, Issue:15 Topics: Alkaline Phosphatase; Animals; Antineoplastic Agents, Phytogenic; Body Weight; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Etoposide; HeLa Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Naphthalenes; Neoplasms, Experimental; Oligopeptides; Organophosphorus Compounds; Particle Size; Structure-Activity Relationship	2018
Population pharmacokinetics of carboplatin, etoposide and melphalan in children: a re-evaluation of paediatric dosing formulas for carboplatin in patients with normal or mild impairment of renal function. British journal of clinical pharmacology, 2019, Volume: 85, Issue:1 Topics: Age Factors; Antineoplastic Agents; Area Under Curve; Body Weight; Carboplatin; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Dosage Calculations; Etoposide; Female; Glomerular Filtration Rate; Humans; Infant; Kidney; Male; Melphalan; Models, Biological; Neuroblastoma	2019
Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphoma. British journal of haematology, 2008, Volume: 143, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carmustine; Chi-Square Distribution; Cohort Studies; Cytarabine; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Length of Stay; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Mucositis; Recurrence; Risk; Statistics, Nonparametric; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome	2008
Reduction of atherosclerotic lesions in rabbits treated with etoposide associated with cholesterol-rich nanoemulsions. International journal of nanomedicine, 2011, Volume: 6 Topics: Animals; Atherosclerosis; Body Weight; Cholesterol; Eating; Emulsions; Erythrocytes; Etoposide; Histocytochemistry; Leukocytes; Lipoproteins; Male; Nanostructures; Rabbits; Receptors, LDL; Toxicity Tests	2011
Preoperative irradiation combined with chemotherapy impairs healing of bronchial anastomosis during the early postoperative period in rats. The Tohoku journal of experimental medicine, 2003, Volume: 199, Issue:1 Topics: Anastomosis, Surgical; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Body Weight; Bronchi; Cisplatin; Etoposide; Hydroxyproline; Leukocyte Count; Male; Pressure; Radiation-Sensitizing Agents; Rats; Rats, Wistar; Wound Healing	2003
Bombesin/gastrin-releasing peptide receptor: a potential target for antibody-mediated therapy of small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Oct-15, Volume: 9, Issue:13 Topics: Animals; Antibodies, Monoclonal; Blotting, Western; Body Weight; Bombesin; Carcinoma, Non-Small-Cell Lung; CD56 Antigen; Cell Division; Cell Line, Tumor; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Flow Cytometry; Humans; Immunotherapy; Interferon-gamma; Lung Neoplasms; Mice; Mice, SCID; Models, Chemical; Monocytes; Neoplasm Transplantation; Paclitaxel; Protein Binding; Receptors, Bombesin; Thymidine	2003
Enhancement of chemotherapeutic response of tumor cells by a heme oxygenase inhibitor, pegylated zinc protoporphyrin. International journal of cancer, 2004, Volume: 109, Issue:1 Topics: Animals; Annexin A5; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Body Weight; Camptothecin; Cell Line, Tumor; Cisplatin; Coloring Agents; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Etoposide; Heme Oxygenase (Decyclizing); Humans; Hydrogen Peroxide; Male; Metalloporphyrins; Mice; Mitomycin; Neoplasms; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxygen; Polyethylene Glycols; Proline; Reactive Oxygen Species; Tetrazolium Salts; Thiazoles	2004
Chemotherapeutic targeting of etoposide to various tissues on the basis of polyamine level. Journal of drug targeting, 2004, Volume: 12, Issue:1 Topics: Animals; Antineoplastic Agents, Phytogenic; Body Weight; Chromatography, High Pressure Liquid; Etoposide; Male; Organ Size; Organ Specificity; Polyamines; Putrescine; Rats; Rats, Sprague-Dawley	2004
Apoptosis and testicular alterations in albino rats treated with etoposide during the prepubertal phase. The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology, 2004, Volume: 279, Issue:1 Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Body Weight; Cell Count; Dose-Response Relationship, Drug; Epithelium; Etoposide; Female; Fertility; Male; Rats; Rats, Wistar; Seminiferous Tubules; Sertoli Cells; Sexual Maturation; Spermatogonia; Testis	2004
Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1). Cancer cell, 2005, Volume: 7, Issue:6 Topics: Animals; Body Weight; CDC2-CDC28 Kinases; Cell Cycle; Cell Cycle Proteins; Cell Proliferation; Cell Transformation, Neoplastic; Cells, Cultured; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Cyclins; DNA Damage; Embryo, Mammalian; Etoposide; Fibroblasts; Gene Expression; Hyperplasia; Mice; Mice, Knockout; Mice, Nude; Mutation; Pituitary Neoplasms; Retinal Dysplasia; Retroviridae; Transfection; Tumor Suppressor Proteins	2005
Enhanced inhibitory effect of the matrix metalloproteinase inhibitor Ro 28-2653 in combination with estramustine and etoposide on the prostate carcinoma in the rat Dunning orthotopic tumor model. Cancer chemotherapy and pharmacology, 2007, Volume: 59, Issue:2 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Estramustine; Etoposide; Humans; Injections, Intraperitoneal; Male; Neoplasm Invasiveness; Neoplasm Transplantation; Piperazines; Prostatic Neoplasms; Pyrimidines; Rats; Time Factors; Tissue Inhibitor of Metalloproteinases	2007
Successful peripheral blood stem cell harvest on a 5.5-kg infant. Journal of clinical apheresis, 2006, Volume: 21, Issue:4 Topics: Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Blood Volume; Body Weight; Brain Neoplasms; Cisplatin; Citric Acid; Combined Modality Therapy; Cyclophosphamide; Ependymoma; Etoposide; Female; Glucose; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heparin; Humans; Infant; Leukapheresis; Peripheral Blood Stem Cell Transplantation	2006
[Nutritional pathway for autologous stem cell transplantation]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:8 Topics: Antineoplastic Agents, Alkylating; Body Weight; Carboplatin; Critical Pathways; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Melphalan; Multiple Myeloma; Parenteral Nutrition, Total; Transplantation Conditioning; Transplantation, Autologous	2007
[Results of drug therapy of inoperable non-small cell lung carcinoma with VP 16-213 (Etoposide) and cis-platin. A phase II study]. Onkologie, 1983, Volume: 6, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcinoma; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged	1983
cis-Platinum (DDP) and VP 16-213 (etoposide) combination chemotherapy for advanced non-small cell lung cancer. A phase II clinical trial. European journal of cancer & clinical oncology, 1984, Volume: 20, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Pulmonary Atelectasis; Time Factors	1984
[Chemotherapy of non-small-cell bronchial cancer with a combination of Cis-diamminedichloroplatinum (II) and VP 16-213]. Schweizerische medizinische Wochenschrift, 1981, Sep-05, Volume: 111, Issue:36 Topics: Adenocarcinoma; Body Weight; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Drug Therapy, Combination; Etoposide; Humans; Leukocyte Count; Lung Neoplasms; Podophyllotoxin; Vomiting	1981
Safety and efficacy of intraperitoneal injection of etoposide in oil suspension in mice with peritoneal carcinomatosis. Cancer chemotherapy and pharmacology, 1995, Volume: 36, Issue:3 Topics: Animals; Body Weight; Bone Marrow; Dose-Response Relationship, Drug; Drug Carriers; Etoposide; Injections, Intraperitoneal; Iodine; Iodized Oil; Lethal Dose 50; Male; Mice; Mice, Inbred ICR; Peritoneal Neoplasms; Sesame Oil; Water	1995
Collection and transplantation of peripheral blood stem cells in very small children weighting 20 kg or less. Blood, 1995, Jul-01, Volume: 86, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Component Removal; Blood Preservation; Body Weight; Bone Marrow Diseases; Carboplatin; Catheterization, Central Venous; Catheters, Indwelling; Child, Preschool; Cisplatin; Colony-Forming Units Assay; Combined Modality Therapy; Contraindications; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Infant; Leukemia; Male; Neoplasms; Platelet Transfusion; Retrospective Studies; Safety	1995
In vitro and in vivo effects of cisplatin and etoposide in combination on small cell lung cancer cell lines. Japanese journal of cancer research : Gann, 1994, Volume: 85, Issue:10 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; Neoplasm Transplantation; Transplantation, Heterologous; Tumor Cells, Cultured	1994
The involvement of apoptosis in etoposide-induced thymic atrophy. Toxicology and applied pharmacology, 1994, Volume: 128, Issue:1 Topics: Animals; Apoptosis; Atrophy; Body Weight; Corticosterone; DNA; Dose-Response Relationship, Drug; Electrophoresis, Agar Gel; Etoposide; Flow Cytometry; Male; Organ Size; Radioimmunoassay; Rats; Rats, Inbred F344; Thymus Gland; Time Factors	1994
[Experimental study on the combined treatment of UFT with etoposide against mouse Lewis lung carcinoma]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:2 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; DNA, Neoplasm; Etoposide; Lung Neoplasms; Male; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Tegafur; Tumor Cells, Cultured; Uracil	1993
Low levels of p53 are associated with resistance to tetrachlorodibenzo-p-dioxin toxicity in DBA/2 mice. Pharmacogenetics, 1999, Volume: 9, Issue:2 Topics: Animals; Base Sequence; Body Weight; DNA; Etoposide; Genes, p53; Genotype; Homozygote; Humans; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Organ Size; Polychlorinated Dibenzodioxins; Polymorphism, Single-Stranded Conformational; Promoter Regions, Genetic; Thymus Gland; Tumor Cells, Cultured	1999
Encapsulation in cationic liposomes enhances antitumour efficacy and reduces the toxicity of etoposide, a topo-isomerase II inhibitor. Pharmacology, 2001, Volume: 62, Issue:3 Topics: Animals; Antineoplastic Agents, Phytogenic; Blood Platelets; Body Weight; Capsules; Etoposide; Fibrosarcoma; Leukocytes; Liposomes; Male; Mice; Random Allocation	2001
Collaborative work to evaluate toxicity on male reproductive organs by repeated dose studies in rats 14). Comparison of the effects of 2- and 4-weeks intravenous administration of etoposide. The Journal of toxicological sciences, 2000, Volume: 25 Spec No Topics: Animals; Antineoplastic Agents, Phytogenic; Atrophy; Body Weight; Bone Marrow Cells; Dose-Response Relationship, Drug; Etoposide; Hematopoiesis, Extramedullary; Injections, Intravenous; Male; Organ Size; Rats; Rats, Sprague-Dawley; Spleen; Testis; Thymus Gland; Time Factors; Toxicity Tests	2000
Potential usage of liposomal 4beta-aminoalkyl-4'-O-demethyl-4-desoxypodophyllotoxin (TOP-53) for cancer chemotherapy. Biological & pharmaceutical bulletin, 2002, Volume: 25, Issue:6 Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Antineoplastic Agents; Blood Vessels; Body Weight; Enzyme Inhibitors; Etoposide; Liposomes; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Survival Analysis; Topoisomerase II Inhibitors	2002
Comparison of a water-soluble and a water-insoluble podophyllotoxin derivative in murine neoplasms. Journal of cancer research and clinical oncology, 1979, Volume: 95, Issue:3 Topics: Animals; Body Weight; Etoposide; Liver Neoplasms, Experimental; Mice; Neoplasms, Experimental; Podophyllotoxin; Solubility; Water	1979
[Toxic reduction and superior therapeutic effects on peritoneal carcinomatosis of etoposide particles suspended in oil in mice]. Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:11 Topics: Animals; Body Weight; Delayed-Action Preparations; Etoposide; Infusions, Parenteral; Iodized Oil; Lethal Dose 50; Leukemia P388; Male; Mice; Mice, Inbred ICR; Peritonitis	1991
Anticancer activity of the combination of cisplatin and etoposide in endometrial cancer-bearing nude mice. Gynecologic oncology, 1991, Volume: 41, Issue:1 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Cisplatin; Drug Screening Assays, Antitumor; Etoposide; Female; Mice; Mice, Nude; Uterine Neoplasms	1991
Long-term effects of intravenous hyperalimentation administered during intensive chemotherapy for small cell bronchogenic carcinoma. Cancer, 1987, Jan-15, Volume: 59, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Hypersensitivity, Delayed; Ifosfamide; Lung Neoplasms; Male; Methotrexate; Middle Aged; Parenteral Nutrition, Total; Procarbazine; Prognosis; Vincristine	1987
Comparison between VP 16 and VM 26 in Lewis lung carcinoma of the mouse. European journal of cancer & clinical oncology, 1986, Volume: 22, Issue:2 Topics: Animals; Body Weight; Cell Count; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Etoposide; Kinetics; Leukocyte Count; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Podophyllotoxin; Teniposide	1986
Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1986, Volume: 4, Issue:5 Topics: Adenocarcinoma; Aged; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis; Procarbazine; Progesterone; Prognosis; Serum Albumin; Vinblastine	1986
[Toxicity studies of VP 16-213 (V)--Intravenous three-month toxicity in rats]. The Journal of toxicological sciences, 1986, Volume: 11 Suppl 1 Topics: Anemia; Animals; Body Weight; Eating; Etoposide; Female; Hematologic Tests; Injections, Intravenous; Male; Organ Size; Rats; Rats, Inbred Strains; Testis; Thymus Gland; Time Factors	1986
[Toxicity studies of VP 16-213 (I)--Acute toxicity in mice, rats and rabbits]. The Journal of toxicological sciences, 1986, Volume: 11 Suppl 1 Topics: Administration, Oral; Animals; Body Weight; Etoposide; Female; Injections, Intravenous; Injections, Subcutaneous; Lethal Dose 50; Male; Mice; Organ Size; Rabbits; Rats; Rats, Inbred Strains; Spleen; Thymus Gland	1986
[Toxicity studies of VP 16-213 (II)--Oral one-month subacute toxicity in rats]. The Journal of toxicological sciences, 1986, Volume: 11 Suppl 1 Topics: Administration, Oral; Animals; Body Weight; Etoposide; Female; Hematologic Tests; Kidney; Male; Organ Size; Rats; Rats, Inbred Strains; Testis; Thymus Gland; Time Factors	1986
[Reproduction studies of VP 16-213 (I)--Oral administration to rats prior to and in the early stages of pregnancy]. The Journal of toxicological sciences, 1986, Volume: 11 Suppl 1 Topics: Administration, Oral; Animals; Body Weight; Eating; Embryonic and Fetal Development; Etoposide; Female; Male; Pregnancy; Pregnancy, Animal; Rats; Rats, Inbred Strains; Reproduction; Testis; Thymus Gland	1986
[Reproduction studies of VP 16-213 (II)--Oral administration to rats during the period of fetal organogenesis]. The Journal of toxicological sciences, 1986, Volume: 11 Suppl 1 Topics: Administration, Oral; Animals; Body Weight; Eating; Embryonic and Fetal Development; Etoposide; Female; Genitalia; Gestational Age; Male; Organ Size; Pregnancy; Pregnancy, Animal; Rats; Rats, Inbred Strains; Reflex; Thymus Gland	1986
[Reproduction studies of VP 16-213 (III)--Oral administration to rabbits during the period of fetal organogenesis]. The Journal of toxicological sciences, 1986, Volume: 11 Suppl 1 Topics: Administration, Oral; Animals; Body Weight; Eating; Embryonic and Fetal Development; Etoposide; Female; Fetus; Gestational Age; Male; Organ Size; Pregnancy; Pregnancy, Animal; Rabbits	1986
[Reproduction studies of VP 16-213 (IV)--Oral administration to rats during the perinatal and lactation periods]. The Journal of toxicological sciences, 1986, Volume: 11 Suppl 1 Topics: Administration, Oral; Animals; Body Weight; Etoposide; Female; Lactation; Male; Motor Activity; Organ Size; Postpartum Period; Pregnancy; Pregnancy, Animal; Rats; Rats, Inbred Strains; Reflex; Testis; Thymus Gland	1986
[Reproduction studies of VP 16-213 (V)--Intravenous administration to rats prior to and in the early stages of pregnancy]. The Journal of toxicological sciences, 1986, Volume: 11 Suppl 1 Topics: Animals; Body Weight; Embryonic and Fetal Development; Etoposide; Female; Fertility; Injections, Intravenous; Male; Pregnancy; Pregnancy, Animal; Rats; Rats, Inbred Strains; Testis; Thymus Gland	1986
[Reproduction studies of VP 16-213 (VI)--Intravenous administration to rats during the perinatal and lactation periods]. The Journal of toxicological sciences, 1986, Volume: 11 Suppl 1 Topics: Animals; Animals, Newborn; Body Weight; Etoposide; Female; Injections, Intravenous; Lactation; Male; Motor Activity; Organ Size; Postpartum Period; Pregnancy; Pregnancy, Animal; Rats; Rats, Inbred Strains; Testis; Thymus Gland	1986
[Toxicity studies of VP 16-213 (III)--Oral six-month chronic toxicity in rats]. The Journal of toxicological sciences, 1986, Volume: 11 Suppl 1 Topics: Administration, Oral; Animals; Body Weight; Bone Marrow Cells; Cell Count; Eating; Etoposide; Female; Hematologic Tests; Male; Organ Size; Rats; Rats, Inbred Strains; Testis; Thymus Gland; Time Factors; Urine	1986
[Toxicity studies of VP 16-213 (IV)--Intravenous one-month subacute toxicity in rats]. The Journal of toxicological sciences, 1986, Volume: 11 Suppl 1 Topics: Anemia; Animals; Body Weight; Bone Marrow Cells; Cell Count; Eating; Etoposide; Female; Hematologic Tests; Injections, Intravenous; Kidney; Male; Organ Size; Rats; Rats, Inbred Strains; Testis; Thymus Gland; Time Factors	1986
Circadian rhythm in tolerance of mice for etoposide. Cancer treatment reports, 1985, Volume: 69, Issue:12 Topics: Animals; Body Weight; Circadian Rhythm; Disease Models, Animal; Drug Tolerance; Etoposide; Leukocyte Count; Light; Lung Diseases; Male; Mathematics; Mice; Podophyllotoxin	1985